AVTX-801 D-galactose Supplementation in SLC35A2-CDG

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AVTX-801 D-galactose Supplementation in SLC35A2-CDG	SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation	Not yet recruiting	Phase 2	2026-06-29		NCT05402384

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital of Philadelphia	215
Eva Morava-Kozicz	4
National Institute of Neurological Disorders and Stroke (NINDS)	370
Rare Diseases Clinical Research Network	9

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mayo Clinic Minnesota	Rochester	United States	40

Clinical trials